What are the causes of pancytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Pancytopenia

Pancytopenia results from either bone marrow production failure (hypocellular or ineffective hematopoiesis) or peripheral destruction/sequestration of blood cells, with megaloblastic anemia being the most common reversible cause, followed by aplastic anemia, myelodysplastic syndromes, and hematological malignancies. 1, 2

Primary Etiological Categories

Bone Marrow Disorders (Most Common)

Nutritional/Megaloblastic Causes:

  • Vitamin B12 deficiency and folate deficiency are the leading reversible causes, accounting for up to 74% of cases in some populations 1, 3
  • Vitamin B12 deficiency can present with pancytopenia even without typical macrocytosis or hypersegmented neutrophils, and may mimic hematologic malignancy with fever, lymphadenopathy, and B-symptoms 4
  • Iron deficiency contributes to dimorphic anemia patterns 3

Bone Marrow Failure Syndromes:

  • Aplastic anemia represents 14-18% of cases and carries significant mortality risk 1, 3, 5
  • Myelodysplastic syndromes (MDS) affect approximately 10.7% of cases, characterized by ineffective hematopoiesis and dysplastic changes 1, 6
  • SAMD9/SAMD9L-associated syndromes account for 8-18% of childhood MDS cases 1

Hematological Malignancies:

  • Acute and chronic leukemias, lymphomas, and multiple myeloma account for approximately 16% of cases through direct bone marrow infiltration 1, 6
  • These suppress normal hematopoiesis and determine mortality both through the malignancy itself and infection/bleeding complications 7

Peripheral Destruction and Sequestration

Hypersplenism:

  • Accounts for 10-20% of cases and represents the most common cause of hematologic abnormalities in sarcoidosis 1, 6, 5
  • Results from sequestration rather than production defects 1

Autoimmune Disorders:

  • Systemic lupus erythematosus causes approximately 4.5% of cases 6
  • Hemophagocytic lymphohistiocytosis (HLH) presents with pancytopenia, fever, hepatosplenomegaly, hypertriglyceridemia, hypofibrinogenemia, and markedly elevated ferritin, requiring prompt immunosuppressive treatment 1, 7

Infectious Causes

Viral Infections:

  • HIV and HCV should be tested in all adult patients with pancytopenia 1
  • Dengue, viral hepatitis, and disseminated tuberculosis are documented causes 5

Bacterial Infections:

  • Brucellosis commonly presents with mild transaminitis and pancytopenia, with bone marrow culture having highest diagnostic sensitivity 1
  • Ehrlichiosis (E. chaffeensis) causes pancytopenia with leukopenia and thrombocytopenia, particularly in immunosuppressed patients 1
  • Sepsis itself accounts for 9% of cases 5

Drug-Induced Causes

Chemotherapy Agents:

  • Cause pancytopenia through direct bone marrow suppression and mucosal barrier disruption 1, 7
  • Purine analog-based therapies and alemtuzumab require monitoring for myelosuppression 1

Drug Interactions:

  • Concurrent allopurinol and mercaptopurine use causes life-threatening pancytopenia—mercaptopurine dose must be reduced to 25% when given with allopurinol 8
  • Methotrexate can cause pancytopenia even with low-dose weekly therapy, particularly with impaired renal function or concomitant sulfonamide medications, typically 4-6 weeks after dose increases 1

Immunotherapy:

  • Immune checkpoint inhibitors (anti-CTLA-4 and anti-PD-L1) cause immune-related hematological toxicity in less than 5% of patients but with significant mortality risk 1

Radiation Exposure

  • Acute radiation syndrome causes hematopoietic failure 1

Rare Genetic Syndromes

  • Chediak-Higashi syndrome presents with partial oculocutaneous albinism, bacterial infections, and pancytopenia during accelerated phase 1
  • Griscelli syndrome type 2 manifests with pigmentary dilution and potential HLH development 1

Critical Mortality Considerations

Sepsis is the leading cause of death in pancytopenic patients, with mortality rates of 1.9% in first-line therapy settings, occurring most commonly with severe neutropenia below 100/mcL. 7

  • Approximately 10-20% of patients with neutrophil counts below 100/mcL develop bloodstream infections that can rapidly progress to septic shock 7
  • Fever may be the only early sign of life-threatening infection due to absent inflammatory responses 7
  • Fatal hemorrhage is the second major cause of death (0.4-0.9%), highest when platelets fall below 10,000/μL, with intracranial and gastrointestinal bleeding being most life-threatening 7

High-Risk Populations

  • Children under 10 years have the highest case-fatality rates despite milder initial presentations 1, 7
  • Immunosuppressed patients (HIV, organ transplant, splenectomy) experience more severe symptoms and higher mortality 1, 7
  • Patients with impaired renal function are at increased risk of drug-induced pancytopenia 7

References

Guideline

Pancytopenia Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pancytopenia Diagnosis and Clinical Context

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pancytopenia: a clinico hematological study.

Journal of laboratory physicians, 2011

Research

Bone marrow examination in pancytopenia.

Journal of the Indian Medical Association, 2012

Guideline

Mortality Risks in Pancytopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.